Brief biography of partner
Imperial are a world-leading university for science, technology, engineering, medicine and business (STEMB), where scientific imagination leads to world-changing impact.
We were founded in 1907 with a mission ‘To be useful’, but we know that before anyone can usefully change something, they first need to understand it. That’s what we do.
We use science to try to understand more of the universe, and improve the lives of more people in it. Across our London campuses, and throughout our international network, we ask bigger questions and so we shape the future.
The Division of Cancer has a focus on the translation of high-quality basic research into clinical studies leading to stratified and personalised cancer treatment approaches, which will change NHS practice and provide an outstanding environment for academic and commercial research partnerships. Our educational mission is to create and deliver top quality education to inspire and unite the next generation of healthcare and health science leaders in cancer treatment and research.
Role in the project
Overall, ICL participates in the CSB study and contributes to the miRNA-based detection of ovarian cancer.